8.17

0.74% 0.06

Pre-market: 8.37 0.20 +2.45%

Cartesian Therapeutics Inc (RNAC)

Overview News Price History Option Chain Financials Discussions Forecast

Cartesian Therapeutics Inc stock is traded at $8.17, with a volume of 33,561. It is up +0.74% in the last 24 hours and down -20.06% over the past month. Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Previous Close:

$8.11

Open:

$8.13

24h Volume:

33,561

Relative Volume:

0.39

Market Cap:

$212.44M

Revenue:

$26.00M

Net Income/Loss:

$-219.71M

P/E Ratio:

-0.1641

EPS:

-49.8

Net Cash Flow:

$-51.37M

1W Performance:

-10.81%

1M Performance:

-20.06%

6M Performance:

-31.92%

1Y Performance:

-58.74%

1-Day Range:

$8.0901

$8.38

1-Week Range:

$7.75

$9.49

52-Week Range:

$7.75

$26.50

Cartesian Therapeutics Inc Stock (RNAC) Company Profile

Name

Cartesian Therapeutics Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

301-348-8698

Address

7495 NEW HORIZON WAY, FREDERICK

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

RNAC's Discussions on Twitter

Compare RNAC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RNAC Cartesian Therapeutics Inc	8.17	210.88M	26.00M	-219.71M	-51.37M	-49.80
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-09-25	Initiated	Wedbush	Outperform
Dec-19-24	Initiated	BTIG Research	Buy
Aug-06-24	Initiated	TD Cowen	Buy
Jul-02-24	Downgrade	Oppenheimer	Outperform → Perform
Jun-04-24	Initiated	Oppenheimer	Outperform
May-24-24	Initiated	Mizuho	Buy
Apr-23-24	Reiterated	H.C. Wainwright	Buy
Apr-23-24	Initiated	Leerink Partners	Outperform
Aug-18-23	Downgrade	SVB Securities	Outperform → Market Perform
Jun-14-22	Reiterated	Needham	Buy
Jun-06-22	Initiated	SVB Leerink	Outperform
Jun-15-21	Initiated	BTIG Research	Buy
Jan-26-21	Upgrade	Mizuho	Neutral → Buy
Oct-01-20	Downgrade	Mizuho	Buy → Neutral
Oct-01-20	Downgrade	William Blair	Outperform → Mkt Perform
Jun-12-20	Downgrade	Stifel	Buy → Hold
Apr-28-20	Initiated	H.C. Wainwright	Buy
Jan-29-20	Initiated	Cantor Fitzgerald	Overweight
Jan-21-20	Initiated	William Blair	Outperform
Jun-27-18	Initiated	Janney	Buy
Mar-30-17	Reiterated	UBS	Buy

View All

Cartesian Therapeutics Inc Stock (RNAC) Latest News

04:19 AM

Key metrics from Cartesian Therapeutics Inc.’s quarterly dataPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com

04:19 AM

01:28 AM

What makes Cartesian Therapeutics Inc. (1S70) stock appealing to growth investorsJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com

01:28 AM

Nov 02, 2025

Is Cartesian Therapeutics Inc. a candidate for recovery playEarnings Trend Report & Verified Entry Point Signals - newser.com

Nov 02, 2025

Will Cartesian Therapeutics Inc. price bounce be sustainableVolume Spike & Daily Growth Stock Tips - newser.com

Nov 02, 2025

How Cartesian Therapeutics Inc. (1S70) stock expands through international marketsJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com

Nov 02, 2025

How to read the order book for Cartesian Therapeutics Inc.2025 Market WrapUp & Community Trade Idea Sharing - newser.com

Nov 02, 2025

Nov 01, 2025

Will Cartesian Therapeutics Inc. stock outperform tech sector in 2025Entry Point & High Conviction Buy Zone Picks - newser.com

Nov 01, 2025

Working capital per share of Cartesian Therapeutics, Inc. – FWB:1S70 - TradingView

Nov 01, 2025

Is Cartesian Therapeutics Inc. stock near bottom after declineWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com

Nov 01, 2025

Combining price and volume data for Cartesian Therapeutics Inc.Quarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com

Nov 01, 2025

Is Cartesian Therapeutics Inc. stock supported by strong fundamentalsJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com

Nov 01, 2025

Will Cartesian Therapeutics Inc. (1S70) stock gain from green policiesBear Alert & Verified Trade Idea Suggestions - newser.com

Nov 01, 2025

How Cartesian Therapeutics Inc. stock performs during Fed tightening cycles2025 Market Trends & Technical Buy Zone Confirmation - newser.com

Nov 01, 2025

Is a relief rally coming for Cartesian Therapeutics Inc. holdersOil Prices & Reliable Entry Point Trade Alerts - newser.com

Nov 01, 2025

Oct 31, 2025